Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study
2024 · Blood Cancer Journal · 89 citations
https://doi.org/10.1038/s41408-024-01003-z
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
9
Papers
181
Citations
4
h-index
2
i10-index
Mark Forsberg is an academic researcher from The University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Multiple Myeloma Research and Treatments & CAR-T cell therapy research. The author has an h-index of 4, co-authored 8 publications.
https://doi.org/10.1038/s41408-024-01003-z
https://doi.org/10.1111/bjh.19700
Click to start Chat